登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688617 证券简称：惠泰医疗公 告编号：2025-042 深圳惠泰医疗器械股份有限公司 关于股东权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 深圳惠泰医疗器械股份有限公司（以下简称"公司"）控股股东深圳迈瑞科技控股有限责任公司（以下 简称"深迈控"）于2025年9月3日通过大宗交易方式增持公司股份655,536股，增持比例为0.46%。 ● 本次权益变动前，深迈控及其一致行动人珠海彤昇投资合伙企业（有限合伙）（以下简称"珠海彤 昇"）合计持有公司股份34,597,913股，占公司总股本的24.54%；本次权益变动后，深迈控及其一致行 动人珠海彤昇合计持有公司股份35,253,449股，占公司总股本的25.00%。 ● 本次权益变动属于增持，不触及要约收购，不会导致公司控股股东或实际控制人发生变化。 公司于近日收到深迈控及其一致行动人出具的《详式权益变动报告书》，现将本次权益变动相关情况公 告如下： 一、信息披露义务人及其 ...

Core Viewpoint - The financial advisory opinion from CITIC Securities confirms the accuracy and completeness of the detailed equity change report for Shenzhen Huatai Medical Devices Co., Ltd, ensuring compliance with relevant laws and regulations [1][2]. Section Summaries Section 1: Definitions - The document defines key terms related to the equity change report, including the parties involved and the nature of the equity change, specifically the acquisition of 655,536 shares, representing 0.46% of the total share capital of Huatai Medical [1]. Section 2: Verification of the Detailed Equity Change Report - The report is divided into thirteen parts, covering various aspects such as the purpose of the equity change, funding sources, and the impact on the listed company. The financial advisor conducted a thorough due diligence process and found the report's content to be true, accurate, and complete [1][2]. Section 3: Verification of the Information Disclosure Obligor - The basic information of Shenzhen Mindray Technology Holdings Co., Ltd is provided, including its registration details, legal representative, and business scope. The advisor confirms that the entity is legally established and has the qualifications for the equity change [2][3]. Section 4: Financial Status of the Information Disclosure Obligor - Financial data for Shenzhen Mindray Technology Holdings over the last three years is presented, showing total assets of approximately 1.6 billion yuan in 2024, with a net profit of about 85 million yuan. The company has maintained a low debt ratio of 15.36% [7][8]. Section 5: Legal and Compliance History - The information disclosure obligor has not faced any administrative or criminal penalties in the last five years, nor has it been involved in significant civil litigation or arbitration related to economic disputes [7][8]. Section 6: Management Verification - The document verifies the qualifications of the executive director and supervisor of the information disclosure obligor, confirming no legal issues in the past five years [7][8]. Section 7: Shareholding in Other Companies - The advisor confirms that the information disclosure obligor and its controlling shareholders do not hold more than 5% of shares in any other listed companies, aside from their interests in Mindray Medical and Huatai Medical [7][8]. Section 8: Verification of Consistent Action Parties - The document provides details about Zhuhai Tongsheng Investment Partnership, including its registration, capital contribution, and business scope. The advisor confirms its legal establishment and compliance with regulations [8].